Such NB-EVs isolated from patient plasma consisted of genetic mutations in some of the known oncogenes and tumor suppressor genes in NB (like ALK, CHD5, SHANK2, TERT, FGFR1, PHOX2B and BRAF) (153). This evidence concerns the gene ALK and neuroblastoma.